Evidence map›Paper›PMID 38717046›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder.

Jaime Ramos-Cejudo, June K Corrigan, Chunlei Zheng, Kaitlin N Swinnerton, Sean R Jacobson, Jennifer La, Rebecca A Betensky, Ricardo S Osorio, Sharon Madanes, Nunzio Pomara and 4 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jaime Ramos-CejudoVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.ORCID 0000-0002-0993-9909
June K CorriganVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Chunlei ZhengVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Kaitlin N SwinnertonVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Sean R JacobsonVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Jennifer LaVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Rebecca A BetenskyDepartment of Biostatistics, NYU School of Global Public Health, New York, New York, USA.
Ricardo S OsorioDepartment of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.
Sharon MadanesDepartment of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.
Nunzio PomaraDepartment of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.
Dan IosifescuDepartment of Psychiatry, New York University (NYU) Grossman School of Medicine, New York, New York, USA.
Mary BrophyVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Nhan V DoVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.
Nathanael R FillmoreVA Boston Cooperative Studies Program, MAVERIC, VA Boston Healthcare System, Boston, Massachusetts, USA.

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
Depression treatment and Aβ dynamics: A study of Alzheimer’s disease riskR01AG070821 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI POMARA, NUNZIO · 2021 to 2025
$3.9M
Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learningR01AG079282 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Hugo Javier Aparicio, LAURA BALCER · 2022 to 2026
$3.4M
Cooperative Studies Program, VA Boston Healthcare SystemNational Alzheimer's Coordinating Center AY2022/23NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG070821NIA NIH HHS R01 AG079282NIH HHS R01AG070821NIH HHS R01AG079282
6 · The paper itself

Abstract

introductionThe use of antidepressants in major depressive disorder (MDD) has been reported to influence long-term risk of Alzheimer's disease (AD) and AD-related dementias (AD/ADRD), but studies are conflicting.

methodsWe used inverse probability weighted (IPW) Cox models with time-varying covariates in a retrospective cohort study among midlife veterans with MDD within the US Veterans Affairs healthcare system from January 1, 2000 to June 1, 2022.

resultsA total of 35,200 patients with MDD were identified. No associations were seen regarding the effect of being exposed to any antidepressant versus no exposure on AD/ADRD risk (events = 1,056, hazard ratio = 0.94, 95% confidence interval: 0.81 to 1.09) or the exposure to specific antidepressant classes versus no exposure. A risk reduction was observed for female patients in a stratified analysis; however, the number of cases was small. DISCUSSION: Our study suggests that antidepressant exposure has no effect on AD/ADRD risk. The association in female patients should be interpreted with caution and requires further attention. HIGHLIGHTS: We studied whether antidepressant use was associated with future dementia risk. We specifically focused on patients after their first-ever diagnosis of depression. We used IPW Cox models with time-varying covariates and a large observation window. Our study did not identify an effect of antidepressant use on dementia risk. A risk reduction was observed in female patients, but the number of cases was small.

Indexed as

Antidepressive AgentsDementiaMajor Depressive DisorderVeteransAgedFemaleHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesRisk FactorsUnited StatesAntidepressive AgentsAlzheimer's diseaseantidepressantsdementia riskdepression

Identifiers

PMID38717046
PMCPMC11180845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.